Royal Bank of Canada’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-35,403
| Closed | -$5K | – | 7201 |
|
|
2024
Q1 | $5K | Sell |
35,403
-421
| -1% | -$59 | ﹤0.01% | 6023 |
|
|
2023
Q4 | $5K | Buy |
35,824
+732
| +2% | +$102 | ﹤0.01% | 6123 |
|
|
2023
Q3 | $6K | Buy |
35,092
+13,149
| +60% | +$2.25K | ﹤0.01% | 6092 |
|
|
2023
Q2 | $68K | Buy |
21,943
+12,055
| +122% | +$37.4K | ﹤0.01% | 5171 |
|
|
2023
Q1 | $26K | Buy |
9,888
+2,188
| +28% | +$5.75K | ﹤0.01% | 5546 |
|
|
2022
Q4 | $11K | Sell |
7,700
-1,804
| -19% | -$2.58K | ﹤0.01% | 6054 |
|
|
2022
Q3 | $16K | Buy |
9,504
+294
| +3% | +$495 | ﹤0.01% | 5749 |
|
|
2022
Q2 | $12K | Sell |
9,210
-43
| -0.5% | -$56 | ﹤0.01% | 5862 |
|
|
2022
Q1 | $22K | Sell |
9,253
-622
| -6% | -$1.48K | ﹤0.01% | 6074 |
|
|
2021
Q4 | $45K | Buy |
9,875
+2,175
| +28% | +$9.91K | ﹤0.01% | 5904 |
|
|
2021
Q3 | $62K | Buy |
7,700
+7,416
| +2,611% | +$59.7K | ﹤0.01% | 5520 |
|
|
2021
Q2 | $3K | Sell |
284
-476
| -63% | -$5.03K | ﹤0.01% | 6693 |
|
|
2021
Q1 | $7K | Buy |
760
+312
| +70% | +$2.87K | ﹤0.01% | 6459 |
|
|
2020
Q4 | $5K | Buy |
+448
| New | +$5K | ﹤0.01% | 6117 |
|
|
2020
Q3 | – | Sell |
-6
| Closed | – | – | 6439 |
|
|
2020
Q2 | $0 | Sell |
6
-692
| -99% | – | ﹤0.01% | 6394 |
|
|
2020
Q1 | $7K | Buy |
698
+597
| +591% | +$5.99K | ﹤0.01% | 5452 |
|
|
2019
Q4 | $1K | Buy |
+101
| New | +$1K | ﹤0.01% | 6099 |
|